Westchester Capital Management (New York)’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Westchester Capital Management (New York)’s Portfolio NRXPW Stock Details NRXPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-122,379	Closed	-$22K	–	133
2019 Q1	$22K	Hold	122,379	–	–	﹤0.01%	114
2018 Q4	$47K	Hold	122,379	–	–	﹤0.01%	109
2018 Q3	$51K	Hold	122,379	–	–	﹤0.01%	113
2018 Q2	$46K	Hold	122,379	–	–	﹤0.01%	102
2018 Q1	$46K	Buy	+122,379	New	+$48K	﹤0.01%	103

Other funds holding NRXPW

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

VAS

VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return

Westchester Capital Management (New York)'s NRXPW Position: Q2 2019 in Review

Westchester Capital Management (New York) sold out of NRX Pharmaceuticals Warrant (NRXPW) in Q2 2019, closing a stake of 122,379 shares — an estimated $22K sold.

Westchester Capital Management (New York) first reported a position in NRXPW in Q1 2018 and held it in 5 quarters. The position peaked at $51K in Q3 2018. 19 funds tracked by Wall St. Rank hold NRXPW as of Q2 2019.

Westchester Capital Management (New York) reported no remaining NRX Pharmaceuticals Warrant position as of Q2 2019 after selling out during the quarter.
Westchester Capital Management (New York) sold 122,379 NRX Pharmaceuticals Warrant shares in Q2 2019, an estimated $22K.
Westchester Capital Management (New York) first reported a position in NRX Pharmaceuticals Warrant in Q1 2018 and held it in 5 quarters.
Westchester Capital Management (New York)'s NRX Pharmaceuticals Warrant position peaked at $51K in Q3 2018.
19 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q2 2019.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2019, filed 14 Aug 2019.